Clinical Trials
9
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Long-Term Follow-Up Study of Patients Receiving ATL001
- Conditions
- Advanced Non Small Cell Lung CancerMelanoma
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Achilles Therapeutics UK Limited
- Target Recruit Count
- 1
- Registration Number
- NCT04785365
- Locations
- 🇬🇧
University College London Hospital (UCLH) NHS Foundation Trust, University College Hospital, London, United Kingdom
ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC
- Conditions
- Advanced Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Achilles Therapeutics UK Limited
- Target Recruit Count
- 27
- Registration Number
- NCT04032847
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
ATL001 in Patients With Metastatic or Recurrent Melanoma
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Achilles Therapeutics UK Limited
- Target Recruit Count
- 13
- Registration Number
- NCT03997474
- Locations
- 🇪🇸
Instituto de Investigación Sanitaria Fundación Jimenez Díaz, Madrid, Spain
🇪🇸Centro Integral Oncologico Clara Campal (CIOCC) Hospital Universitario HM Sanchinarro, Madrid, Spain
🇬🇧Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital, Cambridge, United Kingdom